Purinergic exposure induces epigenomic and transcriptomic-mediated preconditioning resembling epilepsy-associated microglial states.

Microglia play a crucial role in a range of neuropathologies through exacerbated activation. Microglial inflammatory responses can be influenced by prior exposures to noxious stimuli, like increased levels of extracellular adenosine and ATP. These are characteristic of brain insults like epileptic seizures and could potentially shape subsequent responses through epigenetic regulation. We investigated DNA methylation and expression changes in human microglia-like cells differentiated from monocytes following ATP-mediated preconditioning. We demonstrate that microglia-like cells display homeostatic microglial features, shown by surface markers, transcriptome, and DNA methylome. After exposure to ATP, TLR-mediated activation leads to an exacerbated pro-inflammatory response. These changes are accompanied by methylation and transcriptional reprogramming associated with enhanced immune-related functions. The reprogramming associated with ATP-mediated preconditioning leads to profiles found in microglial subsets linked to epilepsy. Purine-driven microglia immune preconditioning drives epigenetic and transcriptional changes that could contribute to altered functions of microglia during seizure development and progression.

The Potential of Circulating Cell-Free DNA Methylation as an Epilepsy Biomarker.

Circulating cell-free DNA (cfDNA) are highly degraded DNA fragments shed into the bloodstream. Apoptosis is likely to be the main source of cfDNA due to the matching sizes of cfDNA and apoptotic DNA cleavage fragments. The study of cfDNA in liquid biopsies has served clinical research greatly. Genetic analysis of these circulating fragments has been used in non-invasive prenatal testing, detection of graft rejection in organ transplants, and cancer detection and monitoring. cfDNA sequencing is, however, of limited value in settings in which genetic association is not well-established, such as most neurodegenerative diseases.Recent studies have taken advantage of the cell-type specificity of DNA methylation to determine the tissue of origin, thus detecting ongoing cell death taking place in specific body compartments. Such an approach is yet to be developed in the context of epilepsy research. In this article, we review the different approaches that have been used to monitor cell-type specific death through DNA methylation analysis, and recent data detecting neuronal death in neuropathological settings. We focus on the potential relevance of these tools in focal epilepsies, like Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis (MTLE-HS), characterized by severe neuronal loss. We speculate on the potential relevance of cfDNA methylation screening for the detection of neuronal cell death in individuals with high risk of epileptogenesis that would benefit from early diagnosis and consequent early treatment.

Epilepsy progression is associated with cumulative DNA methylation changes in inflammatory genes.

Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) is the most common focal epilepsy in adults. It is characterized by alarming rates of pharmacoresistance. Epileptogenesis is associated with the occurrence of epigenetic alterations, and the few epigenetic studies carried out in MTLE-HS have mainly focused on the hippocampus. In this study, we obtained the DNA methylation profiles from both the hippocampus and anterior temporal neocortex of MTLE-HS patients subjected to resective epilepsy surgery and autopsied non-epileptic controls. We assessed the progressive nature of DNA methylation changes in relation to epilepsy duration. We identified significantly altered hippocampal DNA methylation patterns encompassing multiple pathways known to be involved in epileptogenesis. DNA methylation changes were even more striking in the neocortex, wherein pathogenic pathways and genes were common to both tissues. Most importantly, DNA methylation changes at many genomic sites varied significantly with epilepsy duration. Such progressive changes were associated with inflammation-related genes in the hippocampus. Our results suggest that the neocortex, relatively spared of extensive histopathological damage, may also be involved in epilepsy development. These results also open the possibility that the observed neocortical impairment could represent a preliminary stage of epileptogenesis before the establishment of chronic lesions or a consequence of prolonged seizure exposure. Our two-tissue multi-level characterization of the MTLE-HS DNA methylome suggests the occurrence of a self-propagating inflammatory wave of epigenetic dysregulation.

Escrita, memória e cuidado - testemunhos de trabalhadores de saúde na pandemia / Writing, memory and care - testimonies by health workers in times of the pandemic / Escritura, memoria y cuidado - testimonios del trabajador de la salud en tiempos de pandemia / Écriture, mémoire et soins - témoignages des travailleurs de la santé en temps de pandêmie

Apresentamos, no presente artigo, o percurso teórico e prático que envolveu a criação do projeto Pausas e Pousos - Vivências do Trabalhador de Saúde em Tempos de Pandemia. A inciativa tem por objetivo conhecer as vivências dos trabalhadores de saúde na pandemia de COVID-19, no cenário nacional. Apresentamos o modo de conhecimento narrativo e o testemunho como uma modalidade particular de produção narrativa, examinando modalidades morais da recepção de testemunhos de profissionais de saúde. Discutimos ainda como o uso de plataformas digitais pode servir como recurso para a produção de memória. Por último, descrevemos a construção de um espaço de escrita, memória, cuidado e diálogo através de intervenções artísticas em ferramentas digitais, afirmando a aposta no poder que o compartilhamento de histórias pode exercer sobre as angústias e sofrimentos emocionais dos trabalhadores de saúde.

This article presents the theoretical and practical path involving the creation of the Pausas e Pousos (Pauses and Landings) Project - Health Worker Experiences in Times of the Pandemic. The initiative aims to take a closer look at the experiences of health workers in the Brazilian scenario of the COVID-19 pandemic. Narrative knowledge and testimony are presented as special modalities of narrative production, analyzing the moral modalities of receiving the health professionals' testimonies. The use of digital platforms as a resource for the production of memories was also discussed. Last, we describe the creation of a space for writing, memories, care and dialogue through artistic interventions using digital tools and highlight the power that sharing stories may have on coping with fear and emotional distress of health workers.

Cet article décrit le cheminement théorique et pratique qui a impliqué la création du projet Pauses et Poses - Expériences de travailleurs de la santé en temps de pandémie. L'initiative vise à connaître les expériences des travailleurs de la santé pendant la pandémie de COVID-19 au Brésil. Nous présentons le mode de connaissance narrative et de témoignage comme un mode particulier de production narrative en examinant les modalités morales de réception des témoignages de professionnels de santé. Ensuite, nous décrivons comment l'utilisation des plateformes digitales peut servir de ressource pour la production de mémoire. Pour finir, nous présentons la construction d'un espace d'écriture, de mémoire, de soins et de dialogue à partir d'interventions artistiques sur les outils numériques, affirmant le pari sur le pouvoir que le partage d'histoires peut exercer sur l'angoisse et la souffrance émotionnelle des travailleurs de la santé.

En este artículo presentamos el camino teórico y práctico de la creación del Proyecto Pausas y Aterrizajes - Experiencias del Trabajador de la Salud en Tiempos de Pandemia. La iniciativa tiene como objetivo conocer las experiencias de los trabajadores de la salud durante la pandemia de COVID-19, en el escenario brasileño. Presentamos el modo de conocimiento narrativo y el testimonio como modalidad particular de producción narrativa, examinando modalidades morales de la recepción de testimonios de los profesionales de la salud. También discutimos cómo el uso de plataformas digitales puede servir como recurso para la producción de memoria. Finalmente, describimos la construcción de un espacio de escritura, memoria, cuidado y diálogo mediante intervenciones artísticas en herramientas digitales, reafirmando el poder que el intercambio de historias puede ejercer sobre la angustia y el sufrimiento emocional de los trabajadores de la salud.

Estrogen receptors genotypes and canine mammary neoplasia.

BACKGROUND: Estrogens are essential for the development and proper function of several hormone-dependent organs. There are, however, several lines of evidence associating estrogens with mammary carcinogenesis. A marked individual genetic variability concerning estrogens biosynthesis, metabolism and mechanism of action was recognized and associated with human breast cancer susceptibility, clinical features and progression. Although some genetic variations in canine ESR1 gene were reported, their influence in clinicopathological features and progression of canine mammary tumors has not been fully evaluated. This study aims to assess the influence of SNPs in ESR1 gene (rs397512133, rs397510462, rs851327560, rs397510612, rs852887655, rs852684753 and rs852398698) in canine mammary tumors characteristics and progression. A group of 155 non-neutered bitches with mammary tumors was included in the study. Follow-up information was assessed 24 months after surgery. RESULTS: Genetic profiles associated with a later onset of mammary tumors and less aggressive clinicopathological features, namely smaller tumor size (≤ 3 cm) with extensive tubular differentiation and low canine-adapted prognostic index (vet-NPI), were identified in this study. CONCLUSIONS: Our data suggest that the ESR1 genetic profile may help on the decision regarding the selection of individual tailored preventive measures against canine mammary tumors development, such as early neutering.

Immunogenetic predisposing factors for mesial temporal lobe epilepsy with hippocampal sclerosis.

PURPOSE: Neuroinflammation appears as an important epileptogenic mechanism. Experimental and clinical studies have demonstrated an upregulation of pro-inflammatory cytokines such as IL-1ß and TNF-α, in mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS). Expression of these cytokines can be modulated by polymorphisms such as rs16944 and rs1800629, respectively, both of which have been associated with febrile seizures (FS) and MTLE-HS development. The human leukocyte antigen (HLA) system has also been implicated in diverse epileptic entities, suggesting a variable role of this system in epilepsy. Our aim was to analyse the association between immunogenetic factors and MTLE-HS development. For that rs16944 (-511 T>C, IL-1ß), rs1800629 (-308 G>A, TNF-α) polymorphisms and HLA-DRB1 locus were genotyped in a Portuguese Population. METHODS: We studied 196 MTLE-HS patients (108 females, 88 males, 44.7 ± 12.0 years, age of onset = 13.6 ± 10.3 years, 104 with FS antecedents) and 282 healthy controls in a case-control study. RESULTS: The frequency of rs16944 TT genotype was higher in MTLE-HS patients compared to controls (14.9% in MTLE-HS vs. 7.7% in controls, p = 0.021, OR [95% CI] = 2.20 [1.13-4.30]). This association was independent of FS antecedents. No association was observed between rs1800629 genotypes or HLA-DRB1 alleles and MTLE-HS susceptibility. Also, no correlation was observed between the studied polymorphisms and disease age of onset. CONCLUSION: The rs16944 TT genotype is associated with MTLE-HS development what may be explained by the higher IL-1ß levels produced by this genotype. High IL-1ß levels may have neurotoxic effects or imbalance neurotransmission leading to seizures.

Interacting Superparamagnetic Iron(II) Oxide Nanoparticles: Synthesis and Characterization in Ionic Liquids.

Interacting superparamagnetic iron(II) oxide nanoparticles (NPs) with sizes of 5.3 ± 1.6 nm were prepared by simple decomposition of [Fe(COT)2] (COT = 1,3,5,7-cyclooctatetraene) with 5 bar of H2 in 1-n-butyl-3-methylimidazolium bis(trifluoromethanesulfonyl)imide (BMI·NTf2) ionic liquid (IL). The static and dynamic magnetic characterization revealed a superparamagnetic behavior with weak dipolar interactions of these NPs. In situ structural studies by X-ray absorption spectroscopy demonstrated that they consist of nanostructured FeO. This approach is an appropriate method to prepare and stabilize nanostructured FeO particles, where the presence of an IL proved to be fundamental to suppress the aggregation and usual overoxidation of the FeO NPs.

The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases.

Autoimmune diseases (AIDs) are characterized by a multifactorial aetiology and a complex genetic background, with the MHC region playing a major role. We genotyped for HLA-DRB1 locus 1228 patients with AIDs-213 with Systemic Lupus Erythematosus (SLE), 166 with Psoriasis or Psoriatic Arthritis (Ps + PsA), 153 with Rheumatoid Arthritis (RA), 67 with Systemic Sclerosis (SSc), 536 with Multiple Sclerosis (MS), and 93 with Myasthenia Gravis (MG) and 282 unrelated controls. We confirmed previously established associations of HLA-DRB1(∗)15 (OR = 2.17) and HLA-DRB1(∗)03 (OR = 1.81) alleles with MS, HLA-DRB1(∗)03 with SLE (OR = 2.49), HLA-DRB1(∗)01 (OR = 1.79) and HLA-DRB1(∗)04 (OR = 2.81) with RA, HLA-DRB1(∗)07 with Ps + PsA (OR = 1.79), HLA-DRB1(∗)01 (OR = 2.28) and HLA-DRB1(∗)08 (OR = 3.01) with SSc, and HLA-DRB1(∗)03 with MG (OR = 2.98). We further observed a consistent negative association of HLA-DRB1(∗)13 allele with SLE, Ps + PsA, RA, and SSc (18.3%, 19.3%, 16.3%, and 11.9%, resp., versus 29.8% in controls). HLA-DRB1(∗)13 frequency in the AIDs group was 20.0% (OR = 0.58). Although different alleles were associated with particular AIDs, the same allele, HLA-DRB1(∗)13, was underrepresented in all of the six diseases analysed. This observation suggests that this allele may confer protection for AIDs, particularly for systemic and rheumatic disease. The protective effect of HLA-DRB1(∗)13 could be explained by a more proficient antigen presentation by these molecules, favouring efficient clonal deletion during thymic selection.